Mycophenolate mofetil and Breast infection - a phase IV clinical study of FDA data

Summary:

Breast infection is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are female, 60+ old, also take Tacrolimus, and have Disseminated tuberculosis.

The phase IV clinical study analyzes which people have Breast infection when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Breast infection?

Breast infection is found to be associated with 449 drugs and 749 conditions by eHealthMe. Check the latest studies of Breast infection.

On Jul, 29, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 13 people (0.01%) have Breast infection.

Could Mycophenolate mofetil cause Breast infection?

Among these 13 people:

What is the gender of people who have Breast infection when taking Mycophenolate mofetil? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Breast infection when taking Mycophenolate mofetil? *

What are other drugs people take besides Mycophenolate mofetil? *

Tacrolimus: 6 people, 46.15%
Prednisone: 4 people, 30.77%
Rivaroxaban: 3 people, 23.08%
Rifampin: 3 people, 23.08%
Pyrazinamide: 3 people, 23.08%
Prednisolone: 3 people, 23.08%
Isoniazid: 3 people, 23.08%
Cyclosporine: 3 people, 23.08%
Vancomycin: 1 person, 7.69%
Sulfamethoxazole And Trimethoprim: 1 person, 7.69%

What are other side effects people have besides Breast infection? *

Pleural Effusion (water on the lungs): 4 people, 30.77%
Renal Impairment (severely reduced kidney function): 3 people, 23.08%
Hepatic Function Abnormal: 3 people, 23.08%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 3 people, 23.08%
Serositis (inflammation of the serous tissues of the body): 2 people, 15.38%
Drug Level Decreased: 2 people, 15.38%
Ascites (accumulation of fluid in the abdominal cavity): 2 people, 15.38%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 15.38%
Urinary Tract Infection: 2 people, 15.38%
Cardiac Arrest: 1 person, 7.69%

What are the existing conditions these people have? *

Disseminated Tuberculosis: 2 people, 15.38%
Immunodeficiency Disorders: 1 person, 7.69%
Fungal Infection: 1 person, 7.69%
Abscess (pus): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Breast infection?

- Check whether Breast infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Mycophenolate mofetil (93,460 reports)

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Breast infection:

Breast infection (449 drugs)

Browse all the conditions that are associated with Breast infection:

Breast infection (749 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.